CONTROL OF DENGUE FEVER: THE ROLE OF NURSES
Main Article Content
Keywords
Dengue Fever, Nurses, Medication, Control, Health
Abstract
Due fever is a significant public health concern, particularly in tropical and subtropical regions around the world. This essay explores the role of nurses in the control and management of dengue fever, focusing on the importance of medication in treatment strategies. Methods used in controlling the disease will be discussed, as well as the results of current approaches. The essay concludes with a discussion on the challenges and opportunities for improving dengue fever control, emphasizing the crucial role of nurses and medication in the overall management of the disease.
References
1. World Health Organization. Dengue and severe dengue. Available at: www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
2. Guzman MG, et al. Dengue: a continuing global threat. Nature Reviews Microbiology. 2010; 8(12): S7-S16.
3. Wilder-Smith A, Schwartz E. Dengue in travelers. New England Journal of Medicine. 2005; 353(9): 924-932.
4. Simmons CP, Peiris M. Denvaxia, a live attenuated tetravalent dengue vaccine: Formulated by Institute Pasteur. Clinical Therapeutics. 2016; 38(6): 1277-1280.
5. Capeding MR, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomized, observer-masked, placebo-controlled trial. The Lancet. 2014; 384: 1358-1365.
6. Bhatt S, et al. The global distribution and burden of dengue. Nature. 2013; 496: 504-507.
7. Lowell BB, Rudic RD. Genetics of dengue fever and dengue hemorrhagic fever. Current Topics in Microbiology and Immunology. 2014; 380: 211-225.
8. Halstead SB. Dengue. The Lancet. 2007; 370: 1644-1652.
9. Simmons CP, et al. Pathogenesis of dengue: Challenges to molecular biology. Science. 2007; 31(10): 1283-1284.
10. Harris E. Dengue: a mosquito-transmitted disease of global urbanization. Annual Review of Microbiology. 2019; 73: 493-517.
2. Guzman MG, et al. Dengue: a continuing global threat. Nature Reviews Microbiology. 2010; 8(12): S7-S16.
3. Wilder-Smith A, Schwartz E. Dengue in travelers. New England Journal of Medicine. 2005; 353(9): 924-932.
4. Simmons CP, Peiris M. Denvaxia, a live attenuated tetravalent dengue vaccine: Formulated by Institute Pasteur. Clinical Therapeutics. 2016; 38(6): 1277-1280.
5. Capeding MR, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomized, observer-masked, placebo-controlled trial. The Lancet. 2014; 384: 1358-1365.
6. Bhatt S, et al. The global distribution and burden of dengue. Nature. 2013; 496: 504-507.
7. Lowell BB, Rudic RD. Genetics of dengue fever and dengue hemorrhagic fever. Current Topics in Microbiology and Immunology. 2014; 380: 211-225.
8. Halstead SB. Dengue. The Lancet. 2007; 370: 1644-1652.
9. Simmons CP, et al. Pathogenesis of dengue: Challenges to molecular biology. Science. 2007; 31(10): 1283-1284.
10. Harris E. Dengue: a mosquito-transmitted disease of global urbanization. Annual Review of Microbiology. 2019; 73: 493-517.